Pinnacle Financial Partners (Tennessee)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,451	Closed	-$626K	–	261
2015 Q4	$626K	Hold	4,451	–	–	0.19%	132
2015 Q3	$591K	Hold	4,451	–	–	0.19%	126
2015 Q2	$784K	Buy	4,451 +35	+0.8%	+$6.29K	0.25%	112
2015 Q1	$763K	Buy	4,416 +25	+0.6%	+$4.29K	0.26%	105
2014 Q4	$719K	Sell	4,391 -649	-13%	-$108K	0.25%	108
2014 Q3	$809K	Buy	5,040 +495	+11%	+$76.1K	0.31%	94
2014 Q2	$668K	Buy	4,545 +2,480	+120%	+$344K	0.27%	102
2014 Q1	$286K	Sell	2,065 -190	-8%	-$28.6K	0.13%	136
2013 Q4	$285K	Buy	+2,255	New	+$233K	0.13%	127

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s JAZZ Position: Q1 2016 in Review

Pinnacle Financial Partners (Tennessee) sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2016, closing a stake of 4,451 shares — an estimated $626K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in JAZZ in Q4 2013 and held it in 9 quarters. The position peaked at $809K in Q3 2014. 340 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

Pinnacle Financial Partners (Tennessee) reported no remaining Jazz Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Pinnacle Financial Partners (Tennessee) sold 4,451 Jazz Pharmaceuticals shares in Q1 2016, an estimated $626K.
Pinnacle Financial Partners (Tennessee) first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 9 quarters.
Pinnacle Financial Partners (Tennessee)'s Jazz Pharmaceuticals position peaked at $809K in Q3 2014.
340 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q1 2016, filed 4 May 2016.